These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 32705535)
1. Hydroxysafflor Yellow A of Carthamus Tinctorius L., Represses the Malignant Development of Esophageal Cancer Cells via Regulating NF-κB Signaling Pathway. Chen X; Wang Y; Zhang L; Gao Y Cell Biochem Biophys; 2020 Dec; 78(4):511-520. PubMed ID: 32705535 [TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury. Jin M; Sun CY; Zang BX Chin J Integr Med; 2016 Jan; 22(1):36-41. PubMed ID: 26015073 [TBL] [Abstract][Full Text] [Related]
3. Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice. Yang F; Li J; Zhu J; Wang D; Chen S; Bai X Eur J Pharmacol; 2015 May; 754():105-14. PubMed ID: 25720342 [TBL] [Abstract][Full Text] [Related]
4. [Protective effect of hydroxysafflor yellow A on endothelial cell injury induced by lipopolysaccharide]. Wang X; Zang B; Wu W; Tong J; Jin M Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1650-3. PubMed ID: 22007554 [TBL] [Abstract][Full Text] [Related]
5. Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway. Su D; Lv C Bioengineered; 2021 Dec; 12(2):11533-11543. PubMed ID: 34889713 [TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of hydroxysafflor yellow A against PMN activation induced by LPS]. Wu W; Jin M; Tong J; Wang XF; Zang BX Yao Xue Xue Bao; 2011 Feb; 46(2):153-7. PubMed ID: 21542285 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of hydroxysafflor yellow A on PDGF‑BB‑induced proliferation and migration of vascular smooth muscle cells via mediating Akt signaling. Song Y; Long L; Zhang N; Liu Y Mol Med Rep; 2014 Sep; 10(3):1555-60. PubMed ID: 24939805 [TBL] [Abstract][Full Text] [Related]
8. [Inhibitory action of hydroxysafflor yellow A on inflammatory signal transduction pathway related factors in rats with cerebral cortex ischemia]. Chen TT; Du YJ; Liu XL; Zhu HB Yao Xue Xue Bao; 2008 Jun; 43(6):570-5. PubMed ID: 18822957 [TBL] [Abstract][Full Text] [Related]
9. Effects of hydroxysafflor yellow A on proliferation and collagen synthesis of rat vascular adventitial fibroblasts induced by angiotensin II. Yuan W; Yang D; Sun X; Liu W; Wang L; Li X; Man X; Fu Q Int J Clin Exp Pathol; 2014; 7(9):5772-81. PubMed ID: 25337218 [TBL] [Abstract][Full Text] [Related]
10. MYC/NBS1-Mediated DNA Damage Response is Involved in the Inhibitory Effect of Hydroxysafflor Yellow A on Glioma Cells. Tang D; Huang T; Tian Q; Wang J Drug Des Devel Ther; 2021; 15():1749-1763. PubMed ID: 33953544 [TBL] [Abstract][Full Text] [Related]
11. [Research progress on mechanism of Carthamus tinctorius in ischemic stroke therapy]. Chen JR; Xie XF; Cao XY; Li GM; Yin YP; Peng C Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(17):4574-4582. PubMed ID: 36164862 [TBL] [Abstract][Full Text] [Related]
12. Hydroxysafflor Yellow A Attenuates Lipopolysaccharide-Induced Neurotoxicity and Neuroinflammation in Primary Mesencephalic Cultures. Wang T; Ding YX; He J; Ma CJ; Zhao Y; Wang ZH; Han B Molecules; 2018 May; 23(5):. PubMed ID: 29783643 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological Actions, Molecular Mechanisms, Pharmacokinetic Progressions, and Clinical Applications of Hydroxysafflor Yellow A in Antidiabetic Research. Zhang X; Shen D; Feng Y; Li Y; Liao H J Immunol Res; 2021; 2021():4560012. PubMed ID: 34938814 [TBL] [Abstract][Full Text] [Related]
14. Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways. Liu YL; Liu YJ; Liu Y; Li XS; Liu SH; Pan YG; Zhang J; Liu Q; Hao YY Int Immunopharmacol; 2014 Dec; 23(2):649-57. PubMed ID: 25466274 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats. Jin M; Wang L; Wu Y; Zang BX; Tan L Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256 [TBL] [Abstract][Full Text] [Related]
17. Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer. Wu N; Li J; Luo H; Wang D; Bai X Biomed Pharmacother; 2021 Apr; 136():111227. PubMed ID: 33485070 [TBL] [Abstract][Full Text] [Related]
18. Hydroxysafflor Yellow A Inhibits Aβ Ren M; Zhang M; Zhang X; Wang C; Zheng Y; Hu Y Neurochem Res; 2022 Mar; 47(3):748-761. PubMed ID: 34783973 [TBL] [Abstract][Full Text] [Related]
19. Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress. Wang CY; Liu Q; Huang QX; Liu JT; He YH; Lu JJ; Bai XY Phytomedicine; 2013 May; 20(7):592-9. PubMed ID: 23523101 [TBL] [Abstract][Full Text] [Related]
20. Hydroxysafflor yellow A, a natural compound from Carthamus tinctorius L with good effect of alleviating atherosclerosis. Xue X; Deng Y; Wang J; Zhou M; Liao L; Wang C; Peng C; Li Y Phytomedicine; 2021 Oct; 91():153694. PubMed ID: 34403879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]